Abstract
Tuberculosis is among the most calamitous disease, leading to a high number of deaths worldwide. After the discovery of rifampicin, no new anti-tuberculosis drug has been introduced; however, USFDA approved bedaquiline and delamanid which are limited to the treatment of extensive drug resistance tuberculosis. Fluoroquinolones are already categorized as anti-tuberculosis drugs by the WHO, but Mycobacterium tuberculosis has developed resistance to fluoroquinolones. Due to the overwhelming nature of tuberculosis across the globe, urge the scientific community to develop molecules against Mycobacterium tuberculosis with improved affinity and efficacy. In this review article, we have tried to summarize the role, structure–activity relationship, and current developments of fluoroquinolone derivatives in the management of tuberculosis. The present review will provide better insights to work further in this area.
Graphic abstract
Similar content being viewed by others
References
World Health Organization (WHO). Global report 2020. https://www.who.int/publications/i/item/9789240013131
Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, Ginsberg A, Swaminathan S, Spigelman M, Getahun H, Menzies D, Raviglione M (2016) Nat Rev Dis Prim 2:1
World Health Organization (2019) Fact sheets—TUBERCULOSIS 2019 https://www.who.int/en/news-room/fact-sheets/detail/tuberculosis
TBfacts.org Information about tuberculosis. https://tbfacts.org/tb-statistics-india/
Tripathi KD (2013) Essentials of medical pharmacology, 7th edn. Jaypee Brothers Medical Publishers Ltd, New Delhi, p 765
Revised national tuberculosis control programme 2017–2025. National strategic plan for tuberculosis elimination. New Delhi 110 108
Zijenah LS (2018) The World Health Organization recommended TB diagnostic tools. IntechOpen. https://doi.org/10.5772/intechopen.73070
Ball P (2000) J Antimicrob Chemother 46:17
Feng LS, Liu CM, Wang B, Chai Y, Hao XQ, Meng S, Guo HY (2010) Eur J Med Chem 45:3407
Spies FS, da Silva PE, Ribeiro MO, Rossetti CM, Zaha A (2008) Antimicrob Agents Chemother 52:2947
Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Clin Infect Dis 31:347
Kerns RJ, Rybak MJ, Kaatz GW, Vaka F, Cha R, Grucz G, Diwadkar VU, Ward TD (2003) Bioorg Med Chem Lett 13:1745
Mather R, Karenchak LM, Romanowski EG, Kowalski RP (2002) Am J Ophthalmol 133:463
Ginsburg AS, Grosset JH, Bishai WR (2003) Lancet Infect Dis 3:432
Roy BK (2011) Veterinary pharmacology and toxicology. Kalyani Publishers, New Delhi, p 435
Chang KC, Yew WW, Chan RCY (2010) J Antimicrob Chemother 65:1551
Hillemann D, Rusch-Gerdes S, Richter E (2009) J Clin Microbiol 47:1767
Takiff HE, Salazar L, Guerrero C, Philipp W, Huang WM, Kreiswirth B, Cole ST, Jacobs WRJR, Telenti A (1994) Antimicrob Agents Chemother 38:773
Alangaden GJ, Manavathu EK, Vakulenko SB, Zvonok NM, Lerner SA (1995) Antimicrob Agents Chemother 39:1700
Cheng AF, Yew WW, Chan EW, Chin CM, Hui MM, Chan RC (2004) Antimicrob Agents Chemother 48:596
Pitaksajjakul P, Wongwit W, Punprasit W, Eampokalap B, Peacock S, Ramasoota P (2005) Southeast Asian J Trop Med Public Health 36:228
Lee SG, Tang LL, Lim IH, Wong SY (2002) Int J Infect Dis 6:48
Sun Z, Zhang J, Zhang X, Wang S, Zhang Y, Li C (2008) Int J Antimicrob Agents 31:115
Musser JM (1995) Clin Microbiol Rev 8:496
Matrat S, Veziris N, Mayer C, Jarlier V, Truffot-Pernot C, Camuset J, Bouvet E, Cambau E, Aubry A (2006) Antimicrob Agents Chemother 50:4170
Kocagöz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF (1996) Antimicrob Agents Chemother 40:1768
Wube AA, Hüfner A, Thomaschitz C, Blunder M, Kollroser M, Bauer R, Bucar F (2011) Bioorg Med Chem 19:567
Guzman JD, Wube A, Evangelopoulos D, Gupta A, Hufner A, Basavannacharya C, Rahman MM, Thomaschitz C, Bauer R, McHugh TD, Nobeli I, Prieto JM, Gibbons S, Bucar F, Bhakta S (2011) J Antimicrob Chemother 66:1766
Aubry A, Pan XS, Fisher LM, Jarlier V, Cambau E (2004) Antimicrob Agents Chemother 48:1281
Foroumadi A, Emami S, Mehni M, Moshafi MH, Shafiee A (2005) Bioorg Med Chem Lett 15:4536
Foroumadi A, Emami S, Hassanzadeh A, Rajaee M, Sokhanvar K, Moshafi MH, Shafiee A (2005) Bioorg Med Chem Lett 15:4488
Briguglioa I, Pirasa S, Corona P, Pirisia MA, Jabes D, Carta A (2013) Anti-Infect Agents 11:75
Wang JY, Hsueh PR, Jan IS, Lee LN, Liaw YS, Yang PC, Luh KT (2006) Thorax 61:903
Nath H, Ryoo S (2013) First- and second-line drugs and drug resistance. InTechOpen. https://doi.org/10.5772/54960
Bahuguna A, Rawat DS (2020) Med Res Rev 40:263
Xu Z, Zhang S, Gao C, Zhao F, Lv ZS, Feng LS (2017) Chin Chem Lett 28:159
Devale TL, Parikh J, Miniyar P, Sharma P, Shrivastava B, Murumkar P (2017) Bioorg Chem 70:256
Gabr MT, El-Gohary NS, El-bendary ER, El-Kerdawy MM, Ni N (2017) Eur J Med Chem 128:36
Hu YQ, Zhang S, Xu Z, Lv ZS, Liu CM, Feng LS (2017) Eur J Med Chem 141:335
Hu YQ, Gao C, Zhang S, Xu L, Xu Z, Feng LS, Wu X, Zhao F (2017) Eur J Med Chem 139:22
Wang R, Yin X, Zhang Y, Yan W (2018) Eur J Med Chem 156:580
Sriram D, Aubry A, Yogeeswaria P, Fisher LM (2006) Bioorg Med Chem Lett 16:298
Xu Z, Song XF, Qiang M, Lvdv ZS (2017) J Heterocycl Chem 54:373
Fan YL, Liu M, Zhang F, Zhang S (2018) J Heterocycl Chem 55:1494
Wang HD, Fan YL, Zhou J, Xu Y, Guan J (2018) J Heterocycl Chem 55:1991
Xu Z, Qiang M, Lv Z (2017) Asian J Chem 29:1039
Zhang S, Xu Z, Gao C, Ren QC, Le C, Lv ZS, Fen LS (2017) Eur J Med Chem 138:501
Xu Z, Zhang S, Feng LS, Li XN, Huang GC, Chai Y, Lv ZS, Guo HY, Liu CM (2017) Molecules 22:1171
Carta A, Palomba M, Briguglio I, Corona P, Piras S, Jabes D, Guglierame P, Molicotti P, Zanetti S (2011) Eur J Med Chem 46:320
Carta A, Palomba M, Paglietti G, Molicotti P, Paglietti B, Cannas S, Zanetti S (2007) Bioorg Med Chem Lett 17:4791
Agrawal KM, Talele JS (2013) Med Chem Res 22:818
Dinakaran M, Senthilkumar P, Yogeeswari P, China A, Nagaraja V, Sriram D (2008) Bioorg Med Chem Lett 18:1229
Senthilumar P, Dinakaran M, Banerjee D, Devakaram RV, Yogeeswari P, China A, Nagaraja V, Sriram D (2008) Bioorg Med Chem 16:2558
Sriram D, Senthilkumar P, Dinakaran M, Yogeeswari P, China A, Nagaraja V (2007) J Med Chem 50:6232
Dinakaran M, Senthilkumar P, Yogeeswari P, China A, Nagaraja V, Sriram D (2008) Bioorg Med Chem Lett 16:3408
Senthilkumar P, Dinakaran M, Yogeeswari P, Sriram D, China A, Nagaraja V (2009) Eur J Med Chem 44:345
Hu YQ, Fan J, Son XF (2018) J Heterocycl Chem 55:246
Aziz HA, Moustafa GAI, Abbas SH, Hauk G, Krishna VS, Sriram D, Berger JM, Abuo-Rahma GE-DA (2019) Med Chem Res 28:1272
Beteck RM, Seldon R, Jordaan A, Warner D, Hoppe HC, Laming D, Legoabe LJ, Khanye S (2019) MedChemComm 10:326
Acknowledgements
Authors are thankful to Vice-chancellor, Banasthali Vidyapith for providing financial assistance and necessary facility. The corresponding author is also grateful to Amity University, Haryana.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Joshi, S., Yadav, D. & Yadav, R. Fluoroquinolones: a review on anti-tubercular activity. Monatsh Chem 152, 881–894 (2021). https://doi.org/10.1007/s00706-021-02806-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-021-02806-7